Adaptimmune Therapeutics plc (ADAP)
Adaptimmune Reports Q1 Financial Results and Provides Business Update
Cytokinetics Inc (CYTK)
Cytokinetics Announces Positive Topline Results From MAPLE-HCM
Brainsway Ltd (BWAY)
BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights
Achieve Life Sciences Inc. (ACHV)
Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program
HEALTHY EXTRACTS INC. (HYEX)
Healthy Extracts Reports Record Q1 2025 Results; Remains on Target for 34%+ Growth in 2025
Mereo BioPharma (MREO)
Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights
Minerva Neurosciences Inc (NERV)
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
MediWound Ltd. (MDWD)
MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers
XOMA Corporation (XOMAO)
XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements
Neuroone Medical Technologies Corp (NMTC)
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%